International groups call for oral health to be included in disease prevention strategies - Oral Health Group

A distinct presentation, a growing evidence base, and specialized clinical expertise support formally recognizing postpartum psychosis in the next DSM update. Mena Mirhom, MD, FAPA, a board-certified psychiatrist and Psychiatric Times section editor, argued that postpartum psychosis should be considered for inclusion in the next iteration or update of the DSM. He said the Lindsay Clancy case and the national conversation around it raise the question for good reason. The DSM-5-TR does not list postpartum psychosis as its own diagnosis. Clinicians instead apply a peripartum-onset specifier to mood disorders, or a postpartum-onset specifier to brief psychotic disorder. Both cover onset during pregnancy or within 4 weeks after delivery.1 Mirhom said the current evidence supports a more specific approach. The Case for InclusionMirhom cited 3 lines of evidence. The first is the nature of the condition itself, which presents in a nuanced and distinct way. The second is the growing research literature on postpartum psychosis.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.